Irwin v. Teva Pharmaceuticals USA Inc et al
| Lindsay Irwin |
| Teva Women's Health Inc doing business as Teva Women's Health LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Inc and Coopersurgical Inc |
| 1:2021cv01984 |
| May 10, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 19, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 15 WAIVER OF SERVICE Returned Executed by Lindsay Irwin. Coopersurgical Inc waiver mailed on 5/11/2021, answer due 7/12/2021. (Kassan, Randi) |
| Filing 14 WAIVER OF SERVICE Returned Executed by Lindsay Irwin. The Cooper Companies Inc waiver mailed on 5/11/2021, answer due 7/12/2021. (Kassan, Randi) |
| Filing 13 WAIVER OF SERVICE Returned Executed by Lindsay Irwin. TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. waiver mailed on 5/11/2021, answer due 7/12/2021. (Kassan, Randi) |
| Filing 12 WAIVER OF SERVICE Returned Executed by Lindsay Irwin. Teva Pharmaceuticals USA Inc waiver mailed on 5/11/2021, answer due 7/12/2021. (Kassan, Randi) |
| Filing 11 WAIVER OF SERVICE Returned Executed by Lindsay Irwin. Teva Women's Health LLC waiver mailed on 5/11/2021, answer due 7/12/2021. (Kassan, Randi) |
Filing 10
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
| Civil Case Terminated. (tmf) |
| Filing 9 Case transferred in from District of Texas Northern; Case Number 2:21-cv-00072. Original file certified copy of transfer order and docket sheet received. |
| Filing 8 CONDITIONAL TRANSFER ORDER (CTO 19): The JPML has issued the attached order in MDL No. 2974, and that order has now been filed in the Northern District of Georgia. (daa) [Transferred from Texas Northern on 5/10/2021.] |
|
Filing 7
STANDING ORDER OF REFERENCE to Magistrate Judge Lee Ann Reno. (Ordered by Judge Matthew J. Kacsmaryk on 5/7/2021) (daa) [Transferred from Texas Northern on 5/10/2021.]
|
| Filing 6 SUMMONS Returned Executed as to Teva Women's Health Inc ; served on 4/29/2021. (Kassan, Randi) [Transferred from Texas Northern on 5/10/2021.] |
| Filing 5 Summons Issued as to All Defendants. (daa) [Transferred from Texas Northern on 5/10/2021.] |
| Filing 4 New Case Notes: A filing fee has been paid. Pursuant to Misc. Order 6, Plaintiff is provided the Notice of Right to Consent to Proceed Before A U.S. Magistrate Judge (Judge Reno). Clerk to provide copy to plaintiff if not received electronically. (daa) [Transferred from Texas Northern on 5/10/2021.] |
| Filing 3 CERTIFICATE OF INTERESTED PERSONS/DISCLOSURE STATEMENT by Lindsay Irwin. (Kassan, Randi) [Transferred from Texas Northern on 5/10/2021.] |
| Filing 2 Request for Clerk to issue Civil Summons filed by Lindsay Irwin. (Attachments: #1 Summons: Teva Women's Health, LLC, #2 Summons: Coopersurgical, Inc., #3 Summons: Teva Branded Pharmaceutical Products R&D, Inc., #4 Summons: Teva Pharmaceuticals USA, Inc., #5 Summons: Teva Women's Health, Inc. d/b/a Teva Women's Health, LLC) (Kassan, Randi) [Transferred from Texas Northern on 5/10/2021.] |
| Filing 1 COMPLAINT WITH JURY DEMAND against Coopersurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc. d/b/a Teva Women's Health, LLC, Teva Women's Health, LLC, The Cooper Companies, Inc. filed by Lindsay Irwin. (Filing fee $402; Receipt number 0539-11821801) Plaintiff will submit summons(es) for issuance. In each Notice of Electronic Filing, the judge assignment is indicated, and a link to the # Judges Copy Requirements and # Judge Specific Requirements is provided. The court reminds the filer that any required copy of this and future documents must be delivered to the judge, in the manner prescribed, within three business days of filing. Unless exempted, attorneys who are not admitted to practice in the Northern District of Texas must seek admission promptly. Forms, instructions, and exemption information may be found at www.txnd.uscourts.gov, or by clicking here: # Attorney Information - Bar Membership. If admission requirements are not satisfied within 21 days, the clerk will notify the presiding judge. (Attachments: #1 Cover Sheet) (Kassan, Randi) [Transferred from Texas Northern on 5/10/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
